Johannes J Bonenkamp Selected Research

Johannes J Bonenkamp Research Topics

13	Neoplasms (Cancer) 12/2022 - 04/2009
12	Melanoma (Melanoma, Malignant) 02/2024 - 11/2005
3	Sarcoma (Soft Tissue Sarcoma) 12/2022 - 01/2021
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2018
1	Fatigue 11/2021
1	Pain (Aches) 11/2021
1	Wound Infection (Wound Infections) 11/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Myxoid Liposarcoma 01/2021
1	Hypersensitivity (Allergy) 07/2016
1	Lymphatic Metastasis 01/2016
1	Adenocarcinoma 09/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015
1	Margins of Excision 12/2014
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2012
1	Communicable Diseases (Infectious Diseases) 11/2011
1	Thyroid Nodule (Nodule, Thyroid) 05/2006
1	Sarcoidosis (Schaumann Disease) 12/2005

3	Monophenol Monooxygenase (Tyrosinase)IBA 07/2016 - 04/2009
3	AntigensIBA 07/2016 - 04/2009
2	Imatinib Mesylate (Gleevec)FDA Link 03/2013 - 06/2012
2	VaccinesIBA 11/2011 - 04/2009
2	ferric oxide (iron oxide)IBA 04/2009 - 11/2005
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2022
1	CytokinesIBA 07/2016
1	Peptides (Polypeptides)IBA 07/2016
1	Carboplatin (JM8)FDA LinkGeneric 09/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2015
1	Sunitinib (Sutent)FDA Link 06/2012
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Messenger RNA (mRNA)IBA 04/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2009
1	Indium-111IBA 04/2009
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2006
1	InterferonsIBA 12/2005

7	Therapeutics 02/2024 - 11/2005
3	Radiotherapy 11/2021 - 09/2015
3	Neoadjuvant Therapy 01/2021 - 09/2015
3	Chemoradiotherapy 01/2021 - 09/2015
3	Lymph Node Excision (Lymph Node Dissection) 07/2016 - 12/2014
2	Aftercare (After-Treatment) 12/2022 - 06/2012
2	Immunotherapy 04/2009 - 04/2009
1	Surgical Amputation (Amputations) 03/2022
1	Limb Salvage 03/2022
1	Drug Therapy (Chemotherapy) 11/2021
1	Drug Tapering 01/2021
1	Adjuvant Radiotherapy 12/2016